Search research articles
Contact Us
Filters
Showing results (21-30 of 176) with videos related to
Page
of 18
Sort By:
Expert Review of Neurotherapeutics
|
January 8, 2019
Erenumab for episodic migraine prophylaxis
Lucas Hendrik Overeem, Lars Neeb, Uwe Reuter
Deutsches Arzteblatt International
|
January 23, 2026
Drugs for Migraine Prophylaxis
Hans Christoph Diener, Julia Grans, Uwe Reuter
Expert Review of Clinical Pharmacology
|
June 9, 2020
Cluster headache therapies: pharmacology and mode of action
Jasper Mecklenburg, Margarita Sanchez Del Rio, Uwe Reuter
Expert Opinion on Pharmacotherapy
|
July 28, 2017
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
Bianca Raffaelli, Heike Israel, Lars Neeb, et al.
Lancet (London, England)
|
March 22, 2025
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives
Jan Versijpt, Koen Paemeleire, Uwe Reuter, et al.
Current Opinion in Neurology
|
May 17, 2006
New insights into migraine pathophysiology
Margarita Sanchez-Del-Rio, Uwe Reuter, Michael A Moskowitz
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 3, 2019
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
Uwe Reuter, Candace McClure, Eric Liebler, et al.
Annals of Neurology
|
March 29, 2002
Nuclear factor-kappaB as a molecular target for migraine therapy
Uwe Reuter, Alberto Chiarugi, Hayrunnisa Bolay, et al.
Journal of Neurology
|
January 5, 2010
Multiple cerebral infarctions in a patient with Churg-Strauss syndrome
Leyli Ghaeni, Eberhard Siebert, Florian Ostendorf, et al.
The Journal of Headache and Pain
|
March 3, 2016
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells
Lars Neeb, Peter Hellen, Jan Hoffmann, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 176) with videos related to
Sort By:
Page
of 18
Expert Review of Neurotherapeutics
|
January 8, 2019
Erenumab for episodic migraine prophylaxis
Lucas Hendrik Overeem, Lars Neeb, Uwe Reuter
Deutsches Arzteblatt International
|
January 23, 2026
Drugs for Migraine Prophylaxis
Hans Christoph Diener, Julia Grans, Uwe Reuter
Expert Review of Clinical Pharmacology
|
June 9, 2020
Cluster headache therapies: pharmacology and mode of action
Jasper Mecklenburg, Margarita Sanchez Del Rio, Uwe Reuter
Expert Opinion on Pharmacotherapy
|
July 28, 2017
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
Bianca Raffaelli, Heike Israel, Lars Neeb, et al.
Lancet (London, England)
|
March 22, 2025
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives
Jan Versijpt, Koen Paemeleire, Uwe Reuter, et al.
Current Opinion in Neurology
|
May 17, 2006
New insights into migraine pathophysiology
Margarita Sanchez-Del-Rio, Uwe Reuter, Michael A Moskowitz
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 3, 2019
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
Uwe Reuter, Candace McClure, Eric Liebler, et al.
Annals of Neurology
|
March 29, 2002
Nuclear factor-kappaB as a molecular target for migraine therapy
Uwe Reuter, Alberto Chiarugi, Hayrunnisa Bolay, et al.
Journal of Neurology
|
January 5, 2010
Multiple cerebral infarctions in a patient with Churg-Strauss syndrome
Leyli Ghaeni, Eberhard Siebert, Florian Ostendorf, et al.
The Journal of Headache and Pain
|
March 3, 2016
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells
Lars Neeb, Peter Hellen, Jan Hoffmann, et al.
Page
of 18